RNASEL and prostate carcinoma: To investigate the role of RNase L in prostate cancer cell motility, RNase L levels were knocked-down using shRNA in DU145, PC3 and LNCaP cells and compared to cells expressing endogenous RNase L levels (expressing control non-targeting shRNA) (Figure 5B, inset).